Impact of Cigarette and E-cigarette Menthol Regulation on Current Smokers of Menthol Cigarettes

Sponsor
Medical University of South Carolina (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05896033
Collaborator
National Institutes of Health (NIH) (NIH), University of Minnesota (Other), National Institute on Drug Abuse (NIDA) (NIH)
240
4
46

Study Details

Study Description

Brief Summary

In a 2x2 design, current menthol smokers (N=240) will complete a baseline period before being assigned to a cigarette (menthol or non-menthol) and e-cigarette condition (menthol or tobacco-flavored e-liquid) and receiving a 7-week supply of cigarettes and e-cigarettes. The study builds upon our well-established methodology for simulating tobacco regulatory policies. To model a ban, smokers will be instructed to only use their assigned products. Primary outcomes include cigarette smoking and e-cigarette use during Week 6. However, because a menthol ban may impact the ability to abstain from smoking, the investigators will incentivize participants to abstain from smoking during Week 7 (continued e-cigarette use allowed) and assess the time to first lapse. Participants will complete daily electronic diaries assessing tobacco product use throughout, which will be corroborated by biomarkers for menthol, nicotine, and smoke. Finally, to maximize the utility of these data for FDA regulation, the investigators will assess whether any demographic or baseline smoking characteristics moderate the observed treatment effects, calibrate the treatment effects to the US adult menthol smoking population, and model the effects of menthol regulation in cigarettes and e-cigarettes on smoking and vaping-attributable deaths and life-years lost.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Non-Menthol Cigarettes
  • Behavioral: Tobacco Flavored E-cigarettes
  • Behavioral: Menthol Cigarettes
  • Behavioral: Menthol Flavored E-cigarettes
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
240 participants
Allocation:
Randomized
Intervention Model:
Factorial Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
The Impact of Menthol Regulation for Cigarettes and E-cigarettes on Tobacco Use Patterns for Current Menthol Smokers
Anticipated Study Start Date :
Nov 1, 2023
Anticipated Primary Completion Date :
Jun 30, 2027
Anticipated Study Completion Date :
Aug 31, 2027

Arms and Interventions

Arm Intervention/Treatment
Experimental: Menthol Spectrum Cigarettes and Menthol E-cigarettes

Ppts will be randomly assigned to receive the menthol spectrum cigarettes and Njoy Ace menthol e-cigarettes. Will be used for the duration of the study (8 weeks) starting at the second visit.

Behavioral: Menthol Cigarettes
Ppts will be randomly assigned to a group that receives menthol flavored cigarettes

Behavioral: Menthol Flavored E-cigarettes
Ppts will be randomly assigned to a group that receives menthol flavored e-cigarettes

Experimental: Menthol Spectrum Cigarettes and Tobacco E-cigarettes

Ppts will be randomly assigned to receive the menthol spectrum cigarettes and Njoy Ace tobacco e-cigarettes. Will be used for the duration of the study (8 weeks) starting at the second visit.

Behavioral: Tobacco Flavored E-cigarettes
Ppts will be randomly assigned to a group that receives tobacco flavored e-cigarettes

Behavioral: Menthol Cigarettes
Ppts will be randomly assigned to a group that receives menthol flavored cigarettes

Experimental: Non-menthol Spectrum Cigarettes and Menthol E-cigarettes

Ppts will be randomly assigned to receive the non-menthol spectrum cigarettes and Njoy Ace menthol e-cigarettes. Will be used for the duration of the study (8 weeks) starting at the second visit.

Behavioral: Non-Menthol Cigarettes
Ppts will be randomly assigned to a group that receives non-menthol cigarettes

Behavioral: Menthol Flavored E-cigarettes
Ppts will be randomly assigned to a group that receives menthol flavored e-cigarettes

Experimental: Non-menthol Spectrum Cigarettes and Tobacco E-cigarettes

Ppts will be randomly assigned to receive the non-menthol spectrum cigarettes and Njoy Ace tobacco e-cigarettes. Will be used for the duration of the study (8 weeks) starting at the second visit.

Behavioral: Non-Menthol Cigarettes
Ppts will be randomly assigned to a group that receives non-menthol cigarettes

Behavioral: Tobacco Flavored E-cigarettes
Ppts will be randomly assigned to a group that receives tobacco flavored e-cigarettes

Outcome Measures

Primary Outcome Measures

  1. Changes in cigarettes per day [Week 1- Week 6]

    Will be measured through week 6 of the study

Secondary Outcome Measures

  1. Fagerstrom Test for Nicotine Dependence [Week 1- Week 7]

    Cigarette Dependence

  2. Ability to abstain from smoking [Week 7]

    Participants will complete a 1-week practice quit attempt in week 7; time to first smoking lapse will be assessed.

Eligibility Criteria

Criteria

Ages Eligible for Study:
21 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  1. adults (21+) who a) have been smoking at least 5 cigarettes daily for one year

  2. usual brand (the brand used most often) is mentholated

  3. have a smartphone that can receive text messages and access the internet (necessary for diary completion).

Exclusion Criteria:
  1. other tobacco and pharmacotherapy criteria

  2. health and safety criteria

  3. planning to move out of the area within the next 3 months

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Medical University of South Carolina
  • National Institutes of Health (NIH)
  • University of Minnesota
  • National Institute on Drug Abuse (NIDA)

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Tracy Smith, Associate Professor-Faculty, Medical University of South Carolina
ClinicalTrials.gov Identifier:
NCT05896033
Other Study ID Numbers:
  • 00122898
  • 1R01DA055985-01A1
First Posted:
Jun 9, 2023
Last Update Posted:
Jun 9, 2023
Last Verified:
May 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Tracy Smith, Associate Professor-Faculty, Medical University of South Carolina
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 9, 2023